External Source

Erin Demakos, Rn And Dr. Louis Silverman Discuss Incidence And Treatment Of Mds In The Us

2015 9:49
Synopsis
ASH 2014- Erin Demakos, RN and Dr. Louis Silverman from the Icahn School of Medicine at Mount Sinai discuss the treatment ...

You Might Also Like

Transfusion Dependence and Transfusion Support in MDS 1:26:19
Transfusion Dependence And Transfusion Support In Mds
2021
National MDS Day 2015 - Erin P Demakos 42:23
National Mds Day 2015 - Erin P Demakos
2015
Advances in our Understanding of the Management of MDS 1:43:41
Advances In Our Understanding Of The Management Of Mds
2022
Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology 6:33
Myelodysplastic Syndromes - Causes, Symptoms, Diagnosis, Tre...
2019
Bone Marrow Blast Response to Overall Survival:Higher-Risk MDS: Rigosertib After Failure of HMAs 7:26
Bone Marrow Blast Response To Overall Survival:higher-risk M...
2015
The Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University 4:29
The Edward P. Evans Center For Myelodysplastic Syndromes (md...
2023
Understanding Myelodysplastic Syndromes (MDS) and Anemia | GoodRx 1:59
Understanding Myelodysplastic Syndromes (mds) And Anemia | G...
2025
How serious a cancer is MDS? What is the prognosis for MDS? 3:38
How Serious A Cancer Is Mds? What Is The Prognosis For Mds?
2018
Understanding the Recent WHO MDS Classification Updates 7:43
Understanding The Recent Who Mds Classification Updates
2017
Myelodysplastic Syndrome (MDS): What you need to know! 38:44
Myelodysplastic Syndrome (mds): What You Need To Know!
2025
Oncologist Lewis Silverman on Revlimid for Patients with Myelodysplastic Syndrome 0:59
Oncologist Lewis Silverman On Revlimid For Patients With Mye...
2015
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.